Table 1.
The Comparison of Baseline Characteristics of the Participants
| Characteristics | Mean ± SD Placebo (n = 21) | Mean ± SD Ellagic acid (n = 22) | P1 |
|---|---|---|---|
| Age (year) | 35.29 ± 5.84 | 34.55 ± 4.93 | 0.611 |
| Weight (kg) | |||
| Baseline | 63.48 ± 9.14 | 63.67 ± 7.91 | 0.941 |
| 2 months Change | 63.03 ± 8.45 | 63.66 ± 7.81 | 0.799 |
| P2 | 0.843 | 0.903 | |
| BMI (kg/m2) | |||
| Baseline | 23.75 ± 1.42 | 23.81 ± 1.34 | 0.827 |
| 2 months Change | 23.61 ± 1.36 | 23.81 ± 1.39 | 0.69 |
| P2 | 0.813 | 0.89 | |
| Physical activity (met h/week) | |||
| Baseline | 36.21 ± 2.91 | 37.53 ± 2.76 | 0.136 |
| 2 months change | 36.72 ± 3.03 | 38.20 ± 2.80 | 0.104 |
| P2 | 0.603 | 0.189 |
Data are expressed as means ± SD.
P1, Comparison of the mean of baseline characteristics between the two groups of ellagic acid and placebo (independent samples t-test); P2, Comparison of mean of baseline characteristics in each group at baseline and end of study (Paired samples t-test).